Thursday , August 17 2017
Home / FT Alphaville / Markets Live: Thursday, 15th December, 2016

Markets Live: Thursday, 15th December, 2016

Summary:
11:02 am BE11:02amHey. Hello. Hi. Morning. J L Morning BE11:03amWelcome to Markets Live, FT Alphaville's daily typing and junk. Patience Good morning all. BE11:03amPortrait then. 11:03 am BE11:03am BarneyBear Morning. Today (or Tonight) is apparently the biggest day for office Xmas parties this year... BE11:03amBut don't look at it! BE11:03amSeriously. Don't. 11:03 am BE11:04amDon't click this link either! BE11:04amhttps://www.ispot....opdivo-longer-life Gross Loydman god morgen BE11:04amYou remember Opdivo, right? 11:04 am BE11:04amOr nivolumab, to give it its real name. Residual BMS's broken drug? CommentGoesHere Morning. I've seen that ad, it's the worst ever example of US pharma ads BE11:05amOne of those potential blockbuster immuno-oncology pills, or immunicorns. Pharma In what way is a drug not chemotherapy? BE11:05amIt's the one that failed a trial for first-line treatment against lung cancer a couple of months ago.

Topics:
Bryce Elder considers the following as important:

This could be interesting, too:

Paul Murphy writes Markets Live: Thursday, 17th August, 2017

Alexandra Scaggs writes Reminder: Your “self-destructing” messages do not actually self-destruct

Matthew C Klein writes Real interest rates aren’t particularly low

Izabella Kaminska writes Further reading

Bryce Elder
Bryce is a sporadic Alphaville contributor and has been the FT’s UK equities reporter since 2008. Before that he wrote about UK equities at Morningstar. Before that he wrote about UK equities at The Times. Before that he wrote about UK equities at Bloomberg. Before that he wrote about UK equities at AFX News. Before that he did not write about UK equities.

Leave a Reply

Your email address will not be published. Required fields are marked *